![]() | Only 14 pages are availabe for public view |
Abstract HAI has a significant and largely avoidable economic impact at both the patient and population levels, including out-of-pocket costs to patients and costs incurred through lost productivity due to morbidity and mortality (Storr et al, 2017). The human and financial costs of treating surgical site infections (SSIs) are increasing. The number of surgical procedures performed in the United States continues to rise, and surgical patients are initially seen with increasingly complex comorbidities. It is estimated that approximately half of SSIs are deemed preventable using evidence-based strategies (Berríos-Torres et al, 2017). Given the limited availability of IPC evidence-based guidance and standards, the world health organization WHO |